SMMT · Summit Therapeutics Inc. · Congressional Trades
$16.91
+0.52 (+3.17%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 23, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 23, 2026
Market Cap
$12.45B
Shares
797.75M
Volume · Sep 30
13.06M
Avg daily vol (3M)
5.57M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.